Nucleus Software Exports (531209) Q1 25/26 earnings summary

Executive summary

• Achieved major go-lives, including a large-scale implementation with over 20,000 users at a major Indian hospital, reflecting strong operational execution and product adoption.

• Board approved audited standalone and unaudited consolidated financial results for the quarter ended June 30, 2025, with both sets reviewed by the Audit Committee and statutory auditors expressing unmodified opinions.

• Continued progress on Lean Journey and Ocean Foundry initiatives, focusing on customer satisfaction, employee development, and long-term sustainability.

• Embedded AI modules in core products are being implemented and leveraged by customers, with further development planned.

• Final dividend of Rs.12.50 per share for FY25 was approved and paid on July 31, 2025.

Financial highlights

• Consolidated revenue for the quarter was INR 217.72 crores, up from INR 195.39 crores year-over-year.

• Net profit for the quarter was INR 35.20 crores, up from INR 30.20 crores year-over-year.

• Product revenue was INR 184.91 crores, up year-over-year; projects and services revenue rose to INR 52.81 crores.

• Total comprehensive income was INR 39.83 crores, up from INR 31.24 crores year-over-year.

• Basic and diluted EPS (consolidated) for Q1 FY26 was Rs.13.37, up from Rs.11.28 in Q1 FY25.

Outlook and guidance

• Management reiterated a focus on fundamentals, lean initiatives, and expanding into new markets, especially North America, but did not provide specific forward-looking guidance.

• Financial statements prepared in accordance with Indian Accounting Standards and reviewed by statutory auditors, with no material misstatements identified.

• Order book of INR 703.16 crores is expected to be implemented over the next nine months.